Dupixent ® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

[
Dupixent ® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)
[og_img]
https://www.investing.com/news/press-releases/dupixent–dupilumab-approved-as-the-firstever-biologic-medicine-in-japan-for-patients-with-chronic-obstructive-pulmonary-disease-copd-93CH-3953546


Investing.com